Abstract:Background: Antimicrobial peptides (AMPs) are promising alternative agents for antibiotics to overcome antibiotic resistance problems. But, it is difficult to produce large-scale antimicrobial research due to the toxicity towards expression hosts or degradation by peptidases in the host. Therefore, heterologous recombinant expression of antimicrobial peptides has always been a challenging issue. Objectives: To overcome toxicity to the expression host and low expression level, a new photocleavable protein fusion expression method for antimicrobial peptides is provided. Methods: Through directed evolution and high throughput screening, a photocleavable protein mutant R6-2-6-4 with a higher photocleavage efficiency was obtained. The DNA coding sequence of antimicrobial peptide Histatin 1 was fused within the sequence of R6-2-6-4 gene. The fusion gene was successfully expressed in Escherichia coli expression system. Results: Antimicrobial peptide Histatin 1 could be successfully expressed and purified by fusing within PhoCl mutant R6-2-6-4. The antimicrobial activity was rarely affected, and the MIC value was 33 ug/mL, which was basically equivalent to 32 ug/mL of the chemically synthesized Histatin 1. After amplification in a 5 L fermenter, the expression of PhoCl mutant (R6-2-6-4)-Histatin1 improved up to 87.6 mg/L in fermenter, and Histatin1 obtained by photocleavage also could up to 11 mg/L. The prepared Histatin1 powder remained stable when stored at 4oC for up to 4 months without any degradation. In addition, the expression and photocleavage of β -Defensin105 and Lysostaphin verified the certain universality of the PhoCl mutant fusion expression system. Conclusion: Antimicrobial peptides Histatin 1, β -Defensin 105 and Lysostaphin were successfully expressed and purified by photocleavable protein mutant. This may provide a novel strategy to express and purify antimicrobial peptides in the Escherichia coli expression system.

Recombinant expression of a novel antimicrobial peptide consisting of human α-defensin 5 and Mytilus coruscus mytilin-1 in Escherichia coli

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

Self-Assembling Myristoylated Human Α-Defensin 5 As a Next-Generation Nanobiotics Potentiates Therapeutic Efficacy in Bacterial Infection.

Recombinant Expression of Antimicrobial Peptides Using a Novel Self-Cleaving Aggregation Tag Inescherichia Coli

High-level Production of Bioactive Human Beta-Defensin-4 in Escherichia Coli by Soluble Fusion Expression

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

Soluble Fusion Expression and Characterization of Human Beta-Defensin 3 Using a Novel Approach.

Recent advances in the research and development of human defensins.

Expression and purification of moricin CM4 and human β-defensins 4 in Escherichia coli using a new technology.

Design, characterization and expression of a novel hybrid peptides melittin (1–13)-LL37 (17–30)

Molecular characterization of a novel antimicrobial peptide from Mytilus coruscus

High-Level Production of a Novel Antimicrobial Peptide Perinerin in Escherichia Coli by Fusion Expression

Potential Therapeutic Efficacy of a Bactericidal–immunomodulatory Fusion Peptide Against Methicillin-Resistant Staphylococcus Aureus Skin Infection

Improving Photocleavage Efficiency of Photocleavable Protein for Antimicrobial Peptide Histatin 1 Expression

Expression and Purification of Two Different Antimicrobial Peptides, PR-39 and Protegrin-1 in Escherichia Coli.

Design and production of a novel antimicrobial fusion protein in Escherichia coli

Extracellular production of antifungal peptides from oxidative endotoxin-free E. coli and application

Fusion Expression of Human β-Defensin DEFB113 and Its Biological Activities

Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33

Utilization of a recombinant defensin from Maize (Zea mays L.) as a potential antimicrobial peptide

High efficiency preparation of bioactive human α-defensin 6 in Escherichia coli Origami(DE3)pLysS by soluble fusion expression